| Agility to Attend Upcoming Investor Conferences |
Globe Newswire |
11/09 |
07:00 |
| Can-Fite Reports Ten-Year Survival Milestone for Advanced Liver Cancer Patient from Phase II Namodenoson Study |
Globe Newswire |
11/09 |
07:00 |
| Adagene Announces Completion of Enrollment in Randomized Dose Optimization Phase 2 Trial of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer |
Globe Newswire |
11/09 |
07:00 |
| BlossomHill Therapeutics Announces Outcome from the End-of-Phase 1 Meeting with the FDA and Pivotal Phase 2 Trial Design for OMNI-EGFR™ Inhibitor, BH-30643, in EGFR C797S-Positive NSCLC |
Globe Newswire |
11/09 |
07:00 |
| GT Biopharma Oral Presentation at the SITC 2026 Annual Meeting |
Globe Newswire |
11/09 |
07:00 |
| CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care |
Globe Newswire |
11/09 |
07:00 |
| PyroGenesis Announces Titanium Powder Contract with Global Aerospace Leader |
Globe Newswire |
11/09 |
07:00 |
| J-Star Holding Co., Ltd. Highlights U.S. Operational Progress with Delegation Visit from Global Tier 1 Carbon Fiber Manufacturer |
Globe Newswire |
11/09 |
07:00 |
| Alternative Ballistics Provides Corporate Update Highlighting Commercialization Momentum and Expanding Distribution Network |
Globe Newswire |
11/09 |
07:00 |
| Beyond Oil Announces Non-Brokered Private Placement of Up to C$20 Million |
Globe Newswire |
11/09 |
07:00 |
| Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference |
Globe Newswire |
11/09 |
07:00 |
| Hain Celestial Reports Fiscal First Quarter 2027 Financial Results |
Globe Newswire |
11/09 |
07:00 |
| DecisionHR Announces CEO Succession |
Globe Newswire |
11/09 |
07:00 |
| Fervo Energy Reports Third Quarter 2026 Results |
Globe Newswire |
11/09 |
07:00 |
| Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights |
Globe Newswire |
11/09 |
07:00 |
| Tonix Pharmaceuticals Reports Third Quarter 2026 Financial Results and Operational Highlights |
Globe Newswire |
11/09 |
07:00 |
| Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended September 30, 2026 |
Globe Newswire |
11/09 |
07:00 |
| Editas Medicine Announces Third Quarter 2026 Results and Business Updates |
Globe Newswire |
11/09 |
07:00 |
| Auddia Highlights Accelerating Interest in Patented LT350 Distributed AI Datacenter Technology Following Election as Opposition to Traditional Data Centers Intensifies |
Globe Newswire |
11/09 |
07:00 |
| Tiziana Life Sciences to Present at BIO-Europe 2026 and Host KOL Webcast |
Globe Newswire |
11/09 |
07:00 |
| Charming Medical Limited Announces Nasdaq Delisting Determination and Suspension of Trading |
Globe Newswire |
11/09 |
07:00 |
| Brady Corporation Strengthens Board with Finance and Technology Leaders Scott J. Robinson and Kenneth J. Spangler |
Globe Newswire |
11/09 |
07:00 |
| LifeStance Health Group Announces Launch of Secondary Public Offering |
Globe Newswire |
11/09 |
06:54 |
| Home Instead Gives Ferris Bueller’s Sister the Day Off She Never Got |
Globe Newswire |
11/09 |
06:45 |
| Bullish appoints Former NYSE President Stacey Cunningham as President |
Globe Newswire |
11/09 |
06:45 |